gptkbp:instanceOf
|
gptkb:brand
gptkb:drug
|
gptkbp:activeIngredient
|
gptkb:somatropin
|
gptkbp:approvalYear
|
1995
|
gptkbp:ATCCode
|
gptkb:H01AC01
|
gptkbp:availableOn
|
cartridge
pre-filled pen
|
gptkbp:contraindication
|
active malignancy
acute critical illness
hypersensitivity to somatropin
|
gptkbp:countryOfOperation
|
gptkb:European_Union
gptkb:United_States
|
gptkbp:FDAApproved
|
yes
|
gptkbp:form
|
solution for injection
|
https://www.w3.org/2000/01/rdf-schema#label
|
Norditropin
|
gptkbp:indication
|
gptkb:Noonan_syndrome
gptkb:Turner_syndrome
gptkb:short_stature_homeobox-containing_gene_(SHOX)_deficiency
growth hormone deficiency
chronic renal insufficiency
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:manufacturer
|
gptkb:Novo_Nordisk
|
gptkbp:mechanismOfAction
|
recombinant human growth hormone
|
gptkbp:pregnancyCategory
|
C (US)
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
gptkbp:sideEffect
|
edema
headache
joint pain
muscle pain
injection site reaction
|
gptkbp:storage
|
refrigerate
|
gptkbp:bfsParent
|
gptkb:HGH
|
gptkbp:bfsLayer
|
6
|